AIP
MRNA icon

Ahrens Investment Partners’s Moderna MRNA Stock Holding History

Ahrens Investment Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$4.61K Buy
+30
New +$4.95K ﹤0.01% 773
2022
Q3 		– Sell
-75
Closed -$11K – 627
2022
Q2 		$11K Sell
75
-192
-72% -$27.4K ﹤0.01% 622
2022
Q1 		$46K Sell
267
-31
-10% -$5.22K 0.01% 412
2021
Q4 		$76K Buy
+298
New +$87.1K 0.03% 338
2020
Q4 		– Sell
-3,075
Closed -$218K – 199
2020
Q3 		$218K Buy
+3,075
New +$214K 0.15% 141

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ahrens Investment Partners's MRNA Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Moderna (MRNA) in Q1 2023: 30 shares worth $4.61K. The stake represents ﹤0.01% of the portfolio and ranks #773 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in MRNA as recently as Q2 2022.

Ahrens Investment Partners first reported a position in MRNA in Q3 2020 and has held it in 5 quarters since. The position peaked at $218K in Q3 2020. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Ahrens Investment Partners held 30 shares of Moderna worth $4.61K as of Q1 2023.
  • Moderna was a new Ahrens Investment Partners position in Q1 2023.
  • Moderna made up ﹤0.01% of Ahrens Investment Partners's portfolio in Q1 2023, its #773 holding.
  • Ahrens Investment Partners first reported a position in Moderna in Q3 2020 and has held it in 5 quarters since.
  • Ahrens Investment Partners's Moderna position peaked at $218K in Q3 2020.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.